Literature DB >> 15735300

A prospective study of off-label use of, abuse of, and dependence on nicotine inhaler.

J R Hughes1, E H Adams, M A Franzon, M K Maguire, J Guary.   

Abstract

OBJECTIVE: To determine the incidence of off-label use of, abuse of, and dependence on prescription nicotine inhaler.
DESIGN: Prospective telephone and internet interviews for six months. PARTICIPANTS: 535 new inhaler users. MAIN OUTCOME: Structured interview about off-label use (that is, use of inhaler for non-cessation reasons or concurrent use of inhaler and cigarettes) and Diagnostic and statistical manual, fourth edition (DSM-IV) and International classification of diseases, 10th edition (ICD-10) criteria for abuse and dependence
RESULTS: Although many used inhaler and cigarettes concurrently at some time (43-55%), few used inhaler for non-cessation reasons (4-9%) and few persisted in off label use (8-16%; 95% confidence interval (CI) 5% to 19%). No participant met ICD-10 criteria for harmful use/abuse (95% CI 0% to 3.3%). Eight subjects (1.4%) appeared to meet DSM-IV or ICD-10 criteria for dependence on inhaler, but none were found dependent in a clinical expert interview (95% CI 0% to 3.3%).
CONCLUSIONS: Although transient concurrent use of inhaler and cigarettes often occurs, use for non-cessation reasons, abuse and dependence are rare.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15735300      PMCID: PMC1747971          DOI: 10.1136/tc.2004.008367

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  19 in total

1.  Telephone versus face-to-face interviewing for household drug use surveys.

Authors:  W S Aquilino
Journal:  Int J Addict       Date:  1992-01

2.  Data to estimate the similarity of tobacco research samples to intended populations.

Authors:  John R Hughes
Journal:  Nicotine Tob Res       Date:  2004-02       Impact factor: 4.244

3.  A comparison of the abuse liability and dependence potential of nicotine patch, gum, spray and inhaler.

Authors:  R West; P Hajek; J Foulds; F Nilsson; S May; A Meadows
Journal:  Psychopharmacology (Berl)       Date:  2000-04       Impact factor: 4.530

4.  Regional deposition of inhaled 11C-nicotine vapor in the human airway as visualized by positron emission tomography.

Authors:  M Bergström; A Nordberg; E Lunell; G Antoni; B Långström
Journal:  Clin Pharmacol Ther       Date:  1995-03       Impact factor: 6.875

5.  Endorsement of DSM-IV dependence criteria among caffeine users.

Authors:  J R Hughes; A H Oliveto; A Liguori; J Carpenter; T Howard
Journal:  Drug Alcohol Depend       Date:  1998-10-01       Impact factor: 4.492

6.  Individual differences in preferences for and responses to four nicotine replacement products.

Authors:  R West; P Hajek; F Nilsson; J Foulds; S May; A Meadows
Journal:  Psychopharmacology (Berl)       Date:  2001-01-01       Impact factor: 4.530

7.  Diagnostic orphans: adolescents with alcohol symptom who do not qualify for DSM-IV abuse or dependence diagnoses.

Authors:  N K Pollock; C S Martin
Journal:  Am J Psychiatry       Date:  1999-06       Impact factor: 18.112

8.  Nicotine nasal spray and vapor inhaler: abuse liability assessment.

Authors:  K J Schuh; L M Schuh; J E Henningfield; M L Stitzer
Journal:  Psychopharmacology (Berl)       Date:  1997-04       Impact factor: 4.530

Review 9.  Risk-benefit assessment of nicotine preparations in smoking cessation.

Authors:  J R Hughes
Journal:  Drug Saf       Date:  1993-01       Impact factor: 5.606

10.  DSM-III-R nicotine dependence in young adults: prevalence, correlates and associated psychiatric disorders.

Authors:  N Breslau; M M Kilbey; P Andreski
Journal:  Addiction       Date:  1994-06       Impact factor: 6.526

View more
  8 in total

1.  Use of nicotine replacement therapy to reduce or delay smoking but not to quit: prevalence and association with subsequent cessation efforts.

Authors:  Douglas E Levy; Anne N Thorndike; Lois Biener; Nancy A Rigotti
Journal:  Tob Control       Date:  2007-12       Impact factor: 7.552

2.  Off-label use of contrast agents.

Authors:  P Reimer; R Vosshenrich
Journal:  Eur Radiol       Date:  2008-02-15       Impact factor: 5.315

3.  [Guidelines for smoking cessation - update 2010].

Authors:  Alfred Lichtenschopf
Journal:  Wien Klin Wochenschr       Date:  2011-05-16       Impact factor: 1.704

4.  Is nicotine replacement therapy overvalued in smoking cessation? Analysis of smokers' and quitters' communication in social media.

Authors:  Terhi Kurko; Kari Linden; Maija Kolstela; Kirsi Pietilä; Marja Airaksinen
Journal:  Health Expect       Date:  2014-10-08       Impact factor: 3.377

5.  Patterns of electronic cigarette use and user beliefs about their safety and benefits: an internet survey.

Authors:  Maciej L Goniewicz; Elena O Lingas; Peter Hajek
Journal:  Drug Alcohol Rev       Date:  2012-09-20

6.  Smokers' use of nicotine replacement therapy for reasons other than stopping smoking: findings from the ITC Four Country Survey.

Authors:  David Hammond; Jessica L Reid; Pete Driezen; K Michael Cummings; Ron Borland; Geoffrey T Fong; Ann McNeill
Journal:  Addiction       Date:  2008-10       Impact factor: 6.526

Review 7.  Clinical strategies to enhance the efficacy of nicotine replacement therapy for smoking cessation: a review of the literature.

Authors:  Matthew J Carpenter; Bianca F Jardin; Jessica L Burris; Amanda R Mathew; Robert A Schnoll; Nancy A Rigotti; K Michael Cummings
Journal:  Drugs       Date:  2013-04       Impact factor: 9.546

8.  Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals.

Authors:  Edward J Mills; Ping Wu; Ian Lockhart; Kumanan Wilson; Jon O Ebbert
Journal:  Tob Induc Dis       Date:  2010-07-13       Impact factor: 2.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.